Sangamo Therapeutics
SGMO
SGMO
148 hedge funds and large institutions have $820M invested in Sangamo Therapeutics in 2017 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 54 increasing their positions, 38 reducing their positions, and 23 closing their positions.
Holders
148
Holders Change
+5
Holders Change %
+3.5%
% of All Funds
3.7%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.12%
New
29
Increased
54
Reduced
38
Closed
23
Calls
$21.1M
Puts
$15.8M
Net Calls
+$5.32M
Net Calls Change
+$1.34M
Top Buyers
1 |
1
Invesco
Atlanta,
Georgia
|
$20.7M |
2 |
![]()
2
Fidelity Investments
Boston,
Massachusetts
|
$42.7M |
3 |
3
BlackRock
New York
|
$101M |
4 |
4
State Street
Boston,
Massachusetts
|
$43.4M |
5 |
5
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$15.3M |